Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-05-10
2010-06-22
Krass, Frederick (Department: 1612)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C514S359000
Reexamination Certificate
active
07741495
ABSTRACT:
A series of indoline-sulfonamide compounds is disclosed. The formula of indoline-sulfonamide compounds is shown as formula (I). In formula (I), R1is H or halogen; R2is Ar, Ar—C(O)—, Ar—CH2—, Ar—SO2—, Ar—O—C(O),or R″—C(O)—, and Ar is a substituted or unsubstituted C5-C20 aryl, cyclyl, heterocyclyl, or heteroaryl, R′ and R″ independently is C1-C10 alkyl, or C1-C10 alkoxyl; and R3is C5-C15 aryl or C1-C10 alkyl. The indoline-sulfonamide compounds disclosed in the present invention are characterized in inhibiting tubulin polymerization, and treating cancers and other tubulin polymerization-related disorders with a suitable pharmaceutical acceptable carrier.
REFERENCES:
Chang et. al. Journal of Medicinal Chemistry (2006) 49:6656-6659.
Dorwald F. A. (Side reactions in organic synthesis, 2005, Wiley, VCH, Weinheim, p. IX of Preface).
Chang Jang-Yang
Hsieh Hsing-Pang
Liou Jing-Ping
Bacon & Thomas PLLC
Krass Frederick
National Health Research Institutes
Sznaidman Marcos
Taipei Medical University
LandOfFree
Indoline-sulfonamides compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indoline-sulfonamides compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indoline-sulfonamides compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4161379